| 2019-10 | AF8c, a pan-ErbB family inhibitor induces apoptotic cell death by stimulating DR5/Nrf2 via ROS in colorectal cancer cells | Jeong, Soyeon; Farag, Ahmed Karam; Yun, Hye Kyeong; Jeong, Yoon A.; Kim, Dae Yeong; Jo, Min Jee; Park, Seong Hye; Kim, Bo Ram; Kim, Jung Lim; Lee, Dae-Hee; Roh, Eun Joo; Oh, Sang Cheul |
| 2019-01 | Death-associated protein kinase (DAPK) family modulators: Current and future therapeutic outcomes | Farag, Ahmed Karam; Roh, Eun Joo |
| 2022-09 | Design, synthesis, and biological evaluation of pseudo-bicyclic pyrimidine-based compounds as potential EGFR inhibitors | Farag, Ahmed Karam; Ahn, Byung Sun; Yoo, Je Sik; Karam, Reham; Roh, Eun Joo |
| 2020-10 | Diarylurea derivatives comprising 2,4-diarylpyrimidines: Discovery of novel potential anticancer agents via combined failed-ligands repurposing and molecular hybridization approaches | Farag, Ahmed Karam; Hassan, Ahmed H. E.; Chung, Kyung-Sook; Lee, Jeong-Hun; Gil, Hyo-Sun; Lee, Kyung-Tae; Roh, Eun Joo |
| 2019-01-15 | First-in-class DAPK1/CSF1R dual inhibitors: Discovery of 3,5-dimethoxy-N-(4-(4-methoxyphenoxy)-24(6-morpholinopyridin-3-yl)amino) pyrimidin-5-yl)benzamide as a potential anti-tauopathies agent | Farag, Ahmed Karam; Hassan, Ahmed H. E.; Jeong, Hyeanjeong; Kwon, Youngji; Choi, Jin Gyu; Oh, Myung Sook; Park, Ki Duk; Kim, Yun Kyung; Roh, Eun Joo |
| 2017-12-01 | Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders | Farag, Ahmed Karam; Elkamhawy, Ahmed; Londhe, Ashwini M.; Lee, Kyung-Tae; Pae, Ae Nim; Roh, Eun Joo |
| 2015-11-15 | Targeting EGFR/HER2 tyrosine kinases with a new potent series of 6-substituted 4-anilinoquinazoline hybrids: Design, synthesis, kinase assay, cell-based assay, and molecular docking | Elkamhawy, Ahmed; Farag, Ahmed Karam; Viswanath, Ambily Nath Indu; Bedair, Tarek M.; Leem, Dong Gyu; Lee, Kyung-Tae; Pae, Ae Nim; Roh, Eun Joo |
